Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Week, Multicenter, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Lumiracoxib 200mg o.d. in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis

NCT00170872 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Week, Multicenter, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Lumiracoxib 200mg o.d. in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
Not reported
Enrollment
135
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, rheumatoid arthritis